ICC Labs (ICC) Stock Price, News & Analysis

Company Overview

ICC Labs Inc., through its subsidiaries, produces and sells cannabis in Uruguay. It offers recreational cannabis, medicinal cannabis, cannabinoid extracts, and by-products for medicinal, recreational, and industrial use, as well as industrial hemp. The company is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$1.61 to C$1.77
• 50-Day Range: C$1.62 to C$1.62
• 52-Week Range: C$0.87 to C$2.00
• Volume: 646,156 shs
• Average Volume: 799,310 shs
• Market Capitalization: C$223.63 million
• P/E Ratio: 95.29
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ICC Stock Analysis - Frequently Asked Questions

How have ICC shares performed this year?

ICC Labs' stock was trading at C$1.62 at the beginning of the year. Since then, ICC shares have increased by 0.0% and is now trading at C$1.62.
View the best growth stocks for 2024 here.

How do I buy shares of ICC Labs?

Shares of ICC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of ICC Labs own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ICC Labs investors own include Aphria (APHA), Canopy Growth (WEED), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), Emblem (EMC), WeedMD (WMD) and Auxly Cannabis Group (CBWTF).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Cannabis
• Current Symbol: CVE:ICC
• CUSIP: N/A
• CIK: N/A
• Web: www.intcannabiscorp.com
• Phone: +1-604-6892646
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 95.29
• Forward P/E Ratio: 14.73
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 24.84
• Quick Ratio: 8.74

Sales & Book Value

• Annual Sales: C$533,684.00
• Price / Sales: 419.04
• Cash Flow: C$0.06 per share
• Price / Cash Flow: 28.42
• Book Value: C$0.29 per share
• Price / Book: 5.68

Miscellaneous

• Outstanding Shares: 138,046,000
• Free Float: N/A
• Market Cap: C$223.63 million
• Optionable: Not Optionable
• Beta: N/A